Abbott Laboratories to split into two companies
Abbott Laboratories announced plans to split into two publicly traded companies -- one in diversified medical products and the other in research-based pharmaceuticals, marking a significant change in the company's 123-year history.
Abbott has completed the separation of its research-based pharmaceuticals business into AbbVie, a new independent biopharmaceutical company that starts trading today on the New York Stock Exchange.